PROVECTUS BIOPHARMACEUTICALS, INC. - PVCT
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE | History | No change | 100,000 | 5 | 0.0% | 0.0% | 1 | 0 | 0.0% | Q3 2026 | Oct 15, 2026 |
| Atlas Wealth LLC | History | No change | 19,620 | 1 | 0.0% | 0.0% | 2 | 0 | 0.0% | Q2 2026 | Jul 28, 2026 |
| HUNTINGTON NATIONAL BANK | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 13, 2026 |
| Financial Symmetry Inc | History | No change | 10,191 | 0 | — | — | — | 0 | 0.0% | Q3 2026 | Oct 06, 2026 |